Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
06/06/2024 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference | NASDAQ:ORGO | Organogenesis Holdings Inc |
09/05/2024 | 22:25 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ORGO | Organogenesis Holdings Inc |
09/05/2024 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results | NASDAQ:ORGO | Organogenesis Holdings Inc |
02/05/2024 | 13:00 | GlobeNewswire Inc. | Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis | NASDAQ:ORGO | Organogenesis Holdings Inc |
16/04/2024 | 13:30 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 | NASDAQ:ORGO | Organogenesis Holdings Inc |
03/04/2024 | 13:30 | GlobeNewswire Inc. | Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case | NASDAQ:ORGO | Organogenesis Holdings Inc |
29/02/2024 | 22:31 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:ORGO | Organogenesis Holdings Inc |
29/02/2024 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ORGO | Organogenesis Holdings Inc |
29/02/2024 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance | NASDAQ:ORGO | Organogenesis Holdings Inc |
23/02/2024 | 23:24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ORGO | Organogenesis Holdings Inc |
12/02/2024 | 13:30 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference | NASDAQ:ORGO | Organogenesis Holdings Inc |
08/02/2024 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 | NASDAQ:ORGO | Organogenesis Holdings Inc |
02/02/2024 | 15:54 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ORGO | Organogenesis Holdings Inc |
09/01/2024 | 22:43 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:ORGO | Organogenesis Holdings Inc |
09/11/2023 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results | NASDAQ:ORGO | Organogenesis Holdings Inc |
05/10/2023 | 13:30 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023 | NASDAQ:ORGO | Organogenesis Holdings Inc |
28/09/2023 | 15:15 | GlobeNewswire Inc. | Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS | NASDAQ:ORGO | Organogenesis Holdings Inc |
06/09/2023 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference | NASDAQ:ORGO | Organogenesis Holdings Inc |
09/08/2023 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance | NASDAQ:ORGO | Organogenesis Holdings Inc |
10/07/2023 | 13:30 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023 | NASDAQ:ORGO | Organogenesis Holdings Inc |
10/05/2023 | 22:48 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ORGO | Organogenesis Holdings Inc |
10/05/2023 | 22:23 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ORGO | Organogenesis Holdings Inc |
10/05/2023 | 22:05 | GlobeNewswire Inc. | Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results | NASDAQ:ORGO | Organogenesis Holdings Inc |
01/05/2023 | 22:13 | Edgar (US Regulatory) | Annual Report to Security Holders (ars) | NASDAQ:ORGO | Organogenesis Holdings Inc |
01/05/2023 | 22:10 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ORGO | Organogenesis Holdings Inc |
27/04/2023 | 13:30 | GlobeNewswire Inc. | Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors | NASDAQ:ORGO | Organogenesis Holdings Inc |
15/04/2023 | 00:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ORGO | Organogenesis Holdings Inc |
10/04/2023 | 13:30 | GlobeNewswire Inc. | Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023 | NASDAQ:ORGO | Organogenesis Holdings Inc |
06/04/2023 | 15:31 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ORGO | Organogenesis Holdings Inc |
27/03/2023 | 14:00 | GlobeNewswire Inc. | Organogenesis Applauds Findings from the Office of Inspector General | NASDAQ:ORGO | Organogenesis Holdings Inc |